P2X7 receptor modulates inflammatory and functional pulmonary changes induced by silica

PLoS One. 2014 Oct 13;9(10):e110185. doi: 10.1371/journal.pone.0110185. eCollection 2014.

Abstract

Silicosis is an occupational lung disease, characterized by irreversible and progressive fibrosis. Silica exposure leads to intense lung inflammation, reactive oxygen production, and extracellular ATP (eATP) release by macrophages. The P2X7 purinergic receptor is thought to be an important immunomodulator that responds to eATP in sites of inflammation and tissue damage. The present study investigates the role of P2X7 receptor in a murine model of silicosis. To that end wild-type (C57BL/6) and P2X7 receptor knockout mice received intratracheal injection of saline or silica particles. After 14 days, changes in lung mechanics were determined by the end-inflation occlusion method. Bronchoalveolar lavage and flow cytometry analyzes were performed. Lungs were harvested for histological and immunochemistry analysis of fibers content, inflammatory infiltration, apoptosis, as well as cytokine and oxidative stress expression. Silica particle effects on lung alveolar macrophages and fibroblasts were also evaluated in cell line cultures. Phagocytosis assay was performed in peritoneal macrophages. Silica exposure increased lung mechanical parameters in wild-type but not in P2X7 knockout mice. Inflammatory cell infiltration and collagen deposition in lung parenchyma, apoptosis, TGF-β and NF-κB activation, as well as nitric oxide, reactive oxygen species (ROS) and IL-1β secretion were higher in wild-type than knockout silica-exposed mice. In vitro studies suggested that P2X7 receptor participates in silica particle phagocytosis, IL-1β secretion, as well as reactive oxygen species and nitric oxide production. In conclusion, our data showed a significant role for P2X7 receptor in silica-induced lung changes, modulating lung inflammatory, fibrotic, and functional changes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Bronchoalveolar Lavage Fluid
  • Collagen / metabolism
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Immunophenotyping
  • Inflammation / metabolism*
  • Inflammation / pathology*
  • Interleukin-1beta / metabolism
  • Lung / metabolism*
  • Lung / pathology
  • Lung / physiopathology*
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / metabolism
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B / metabolism
  • NIH 3T3 Cells
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Phagocytosis / drug effects
  • Pulmonary Fibrosis / pathology
  • Pulmonary Fibrosis / physiopathology
  • Purinergic P2X Receptor Antagonists / pharmacology
  • Reactive Oxygen Species / metabolism
  • Receptors, Purinergic P2X7 / metabolism
  • Rosaniline Dyes / metabolism
  • Signal Transduction / drug effects
  • Silicon Dioxide / toxicity*
  • Smad2 Protein / metabolism
  • Smad3 Protein / metabolism
  • Transforming Growth Factor beta / metabolism

Substances

  • Interleukin-1beta
  • NF-kappa B
  • Purinergic P2X Receptor Antagonists
  • Reactive Oxygen Species
  • Receptors, Purinergic P2X7
  • Rosaniline Dyes
  • Smad2 Protein
  • Smad3 Protein
  • Transforming Growth Factor beta
  • Nitric Oxide
  • Silicon Dioxide
  • Collagen
  • Nitric Oxide Synthase Type II
  • coomassie Brilliant Blue

Grants and funding

This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnológico do Brasil (CNPq), Instituto Nacional para Pesquisa Translacional em Saúde e Ambiente na Região Amazônica (INCT-INPeTAm/CNPq/MCT), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Programa de Apoio a Núcleos de Excelência (PRONEX), Brazil, to RCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.